Alexis Peyroles

Director/Board Member at OSE IMMUNOTHERAPEUTICS

Net worth: 640 301 $ as of 30/10/2026

Health Technology

Consumer Services

Distribution Services

Profile

Mr. Alexis Peyroles is an Independent Director at OSE Immunotherapeutics SA, a Chief Executive Officer & Director at Betaglue Technologies SpA, a Chairman & Chief Financial Officer at Inside Therapeutics SAS, a Chairman at Aperana Consulting SAS and a Chief Executive Officer at OSE Immunotherapeutics, Inc. He is on the Board of Directors at OSE Immunotherapeutics SA and Betaglue Technologies SpA. Mr. Peyroles was previously employed as a CFO & Head-Business Development by Orphan Synergy Europe-Pharma SA, a Chief Executive Officer by Guerbet Imagem do Brasil Ltda., a Manager-Financial Control by Guerbet SA, a Head-Eastern Europe Business Development by Sanofi-Aventis France SA, and a Head-Financial Control-Baltic States by Sanofi-Aventis Japan.
He received his undergraduate degree from École des Hautes Études Commerciales du Nord and an MBA from Imperial College Business School.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
OSE IMMUNOTHERAPEUTICS SA 1.25%	29/09/2025	293,848 ( 1.25% )	640 301 $	30/10/2026

Alexis Peyroles active positions

Companies	Position	Start
OSE IMMUNOTHERAPEUTICS	Director/Board Member	29/09/2025
Ose Immunotherapeutics, Inc.	Chief Executive Officer	-
Betaglue Technologies SpA Betaglue Technologies SpA Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company that manufacture oncology therapeutic products	Chief Executive Officer	21/09/2025
Aperana Consulting SAS	Chairman	-

All active positions of Alexis Peyroles

Former positions of Alexis Peyroles

Companies	Position	End
OSE IMMUNOTHERAPEUTICS	Chief Executive Officer	15/01/2022
Sanofi-Aventis Japan	Comptroller/Controller/Auditor	-
GUERBET	Comptroller/Controller/Auditor	-
Sanofi-Aventis France SA Sanofi-Aventis France SA Medical DistributorsDistribution Services Wholesales pharmaceutical products	Corporate Officer/Principal	-
Orphan Synergy Europe-Pharma SA Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers	Director of Finance/CFO	-

See the detail of Alexis Peyroles's experience

Education of Alexis Peyroles

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alexis Peyroles's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Guerbet SA Guerbet SA Medical SpecialtiesHealth Technology Engages in research, development and production of X-Rays and its by products	Health Technology
Sanofi-Aventis Japan
École des Hautes Études Commerciales du Nord École des Hautes Études Commerciales du Nord Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sanofi-Aventis France SA Sanofi-Aventis France SA Medical DistributorsDistribution Services Wholesales pharmaceutical products	Distribution Services
Orphan Synergy Europe-Pharma SA Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers	Health Technology
Imperial College Business School Imperial College Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Aperana Consulting SAS
OSE Immunotherapeutics SA OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers	Health Technology
Betaglue Technologies SpA Betaglue Technologies SpA Miscellaneous Commercial ServicesCommercial Services Operates as a biotech company that manufacture oncology therapeutic products	Commercial Services
Ose Immunotherapeutics, Inc.
Guerbet Imagem do Brasil Ltda.